Is Iodine-125 Monotherapy Suitable for the Full Spectrum of Intermediate Risk Prostate Cancer?

Brachytherapy, pp. S582018.

Cited by: 0|Bibtex|Views3|

Code:

Data:

Your rating :
0

 

Tags
Comments